Misc. news stories

People under the influence of psilocybin — the active component of magic mushrooms — report having more profound and original thoughts, but tend to score lower on cognitive tests of creative ability, according to new research published in Translational Psychiatry.

Leonie, 44, knew where her depression came from – but that didn’t make it any easier to live with.

Image from: Ralpharama (Wiki Commons)

Psychiatry has long failed to explain depression. Our research into psilocybin suggests a new approach could offer answers

Psychedelic drug psilocybin, found in magic mushrooms, is as good at reducing symptoms of depression as conventional treatment, a small, early-stage study has suggested.But when it comes to actively improving people’s well-being and ability to feel pleasure, the psychedelic drug may have had a more powerful effect.

There is no shortage of psychological and pharmacological therapies to combat the world’s most widespread mental health issue, major depressive disorder (MDD). However, a significant portion of the affected population fail to respond to many of these traditional therapies

The debate around psychedelic patents reflects a deeper question about how to create a business model that puts values before profits.

In the wake of New York’s decision to legalize marijuana earlier this week, Senate Majority Leader Chuck Schumer (D-NY) says he’s ready to move on federal marijuana reform.

A new study has been published following on from two earlier studies on microdosing. Our body of research tells us some benefits of microdosing may be comparable to other wellness activities such as yoga.

New York state has legalized marijuana for adults and will expunge the criminal records of people previously convicted of crimes that would be legal under the new law.

There is a new generation of drug users out there who possess highly detailed pharmacological and technical knowledge about the drugs they take.

Oregon is about to become the first state in the country to try to build a support infrastructure through which psychedelic mushrooms can be woven into everyday life.

Sapphire Medical Clinic, located in Stirling, is the first medical cannabis clinic authorised by Healthcare Improvement Scotland (HIS) to provide safe access to medical cannabis for patients in Scotland.

Scientists in Denmark believe the psychedelic substance psilocybin might produce rapid and lasting antidepressant effects in part because it enhances neuroplasticity in the brain.

The use of magic mushrooms, ecstasy and other psychedelic drugs to treat mental illnesses, including depression and post-traumatic stress disorder, may be a step closer in Australia, with clinical trials given a $15m grant.

Stop your sobbing – because scientists can do it for you. Using stem cells, Dutch researchers have grown miniature human tear glands capable of “crying”.

A powerful hallucinogenic drug known for its part in shamanic rituals is being trialled as a potential cure for depression for the first time.